GSA Capital Partners’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-60,079
| Closed | -$836K | – | 1661 |
|
|
2021
Q3 | $836K | Buy |
60,079
+12,393
| +26% | +$172K | 0.09% | 395 |
|
|
2021
Q2 | $885K | Buy |
47,686
+31,102
| +188% | +$577K | 0.1% | 310 |
|
|
2021
Q1 | $387K | Buy |
16,584
+2,083
| +14% | +$48.6K | 0.06% | 488 |
|
|
2020
Q4 | $271K | Buy |
+14,501
| New | +$271K | 0.04% | 799 |
|
|
2020
Q2 | – | Sell |
-1,260
| Closed | -$61K | – | 939 |
|
|
2020
Q1 | $61K | Sell |
1,260
-5,607
| -82% | -$271K | 0.02% | 944 |
|
|
2019
Q4 | $391K | Buy |
+6,867
| New | +$391K | 0.05% | 832 |
|
|
2019
Q3 | – | Sell |
-6,020
| Closed | -$271K | – | 1598 |
|
|
2019
Q2 | $271K | Sell |
6,020
-2,943
| -33% | -$132K | 0.03% | 1067 |
|
|
2019
Q1 | $564K | Sell |
8,963
-712
| -7% | -$44.8K | 0.06% | 623 |
|
|
2018
Q4 | $522K | Buy |
9,675
+1,400
| +17% | +$75.5K | 0.06% | 539 |
|
|
2018
Q3 | $831K | Buy |
+8,275
| New | +$831K | 0.05% | 790 |
|
|
2017
Q4 | – | Sell |
-2,000
| Closed | -$122K | – | 1729 |
|
|
2017
Q3 | $122K | Sell |
2,000
-5,325
| -73% | -$325K | 0.01% | 1503 |
|
|
2017
Q2 | $519K | Buy |
7,325
+2,375
| +48% | +$168K | 0.03% | 989 |
|
|
2017
Q1 | $321K | Buy |
+4,950
| New | +$321K | 0.02% | 1342 |
|